RAAS Blockade After Acute Kidney Injury Ups Survival in Diabetic Kidney Disease
Use of the antihypertensive medications improved survival whether or not patients fully recovered from acute kidney injury.
Use of the antihypertensive medications improved survival whether or not patients fully recovered from acute kidney injury.
Study findings support PSMA-PET as a first-line approach for the primary staging of intermediate- to high-risk prostate cancer.
Clinicians are asking whether sodium-glucose cotransporter 2 inhibitors can be continued in patients with kidney failure for their purported cardiovascular benefits.
Studies show “life-sustaining” kidney function from pig xenografts transplanted into brain-dead men.
Neoadjuvant immunotherapy is an attractive alternative to chemotherapy for patients with localized MIBC because of its lower toxicity profile.
Patient comorbidities were among the significant risk factors for kidney function decline.
Differences between the dialysis and nondialysis population were most pronounced during the first Omicron wave, investigators reported.
Preeclampsia is an important risk factor for chronic kidney disease and warrants post-delivery monitoring, according to investigators.
The 5-year number needed to treat to prevent the primary cardiovascular outcome 25 in patients with lower eGFR compared with 67 among those with normal eGFR.
Study findings lend support to placing “the right access in the right patient at the right time” per the 2019 KDOQI guideline rather than using a strict “fistula first” approach.